Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Neoplasms 9Venous Thromboembolism 8Venous Thrombosis 7Pulmonary Embolism 5Thrombosis 4Pancreatic Neoplasms 4Thromboembolism 3Lymphoma 3Small Cell Lung Carcinoma 2Sarcoma 2Ovarian Neoplasms 2Lymphoma, Large B-Cell, Diffuse 2Hemorrhage 2Carcinoma, Non-Small-Cell Lung 2Venous Thormboembolism 1Urinary Bladder Neoplasms 1Thrombocytopenia 1Stroke 1Stomach Neoplasms 1Soft Tissue Neoplasms 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Liver Neoplasms 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1

Interventions

Etoposide 79Carboplatin 67Cisplatin 58durvalumab 29Irinotecan 29Radiotherapy 27atezolizumab 23Topotecan 21anlotinib 19Nivolumab 15Drug Therapy 15Radiosurgery 14Gemcitabine 13apatinib 12Paclitaxel 12toripalimab 10Platinum 10Docetaxel 10tislelizumab 9Temozolomide 9PM 01183 8pembrolizumab 7olaparib 7Magnetic Resonance Spectroscopy 7Ipilimumab 7Bevacizumab 7Albumin-Bound Paclitaxel 7irinotecan sucrosofate 6Counseling 6sintilimab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Small Cell Lung Carcinoma × Enoxaparin × Clear all
NCT00717938 2017-08-25

RASTEN

Lund University Hospital

Phase 3 Completed
390 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT00916669 2013-05-08

A Randomized Study to Evaluate the Effect of Two Different Doses of Enoxaparin Sodium in Combination With Standard Chemotherapy in Patients With Stage Small Cell Lung Cancer (SCLC)

Massachusetts General Hospital

Phase 2 Withdrawn
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡